AVLAYAH™ (tividenofusp alfa-eknm)
| Full Name | AVLAYAH™ (tividenofusp alfa-eknm) |
| Drug | tividenofusp |
| Manufacturer | Denali Therapeutics Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of neurologic manifestations of Hunter syndrome (Mucopolysaccharidosis type II, MPS II) when initiated in presymptomatic or symptomatic pediatric patients weighing at least 5 kg prior to advanced neurologic impairment |
| Disease | Mucopolysaccharidosis II (MPS II) |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | |
| Phone Number | 800-240-9572 |
| Fax Number | 847-427-7976 |
| Product Website | avlayah.com |
| Patient Resources | National MPS Society |